Discover 644 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 644
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
for
Death; Neonatal, Morbidity;Newborn
Location: Watertown WI, Fort Atkinson WI, Columbus WI, Madison WI,
Sponsor: Mayo Clinic
Sex: All
Age: 0+
Code: NCT06087224
Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Johnson Creek WI, Rockford IL, Madison WI, Chicago IL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
for
Chemotherapy Induced Neuropathic Pain,
Location: Gurnee IL, Madison WI, Fenton MO, Williamsville NY,
Sponsor: Dogwood Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06848348
Phase2, Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Grayslake IL, Lake Forest IL, Glenview IL, Chicago IL,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06686771
Phase3, Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Grayslake IL, Lake Forest IL, Glenview IL, Chicago IL,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06769126
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Grayslake IL, Lake Forest IL, Glenview IL, Chicago IL,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase2, Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Grayslake IL, Lake Forest IL, Highland Park IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase3, Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
for
Castration-Resistant Prostate Carcinoma,
Location: Grayslake IL, Lake Forest IL, Glenview IL, Chicago IL,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT06470243
Phase3, Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
for
Metastatic Malignant Neoplasm in the Liver,
Location: Grayslake IL, Lake Forest IL, Glenview IL, Rockford IL,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05040360
Phase2, Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for
Malignant Female Reproductive System Neoplasm,
Location: Sheboygan WI, Highland Park IL, Glenview IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06126276
Phase2, Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Sheboygan WI, Ann Arbor MI, Detroit MI, Des Moines IA,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Sheboygan WI, Chicago IL, Dyer IN, Urbana IL,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase3, Recruiting
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
for
Angioimmunoblastic T-cell Lymphoma,
Location: Libertyville IL, Lake Forest IL, Madison WI, Chicago IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT04803201
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
for
Mid Face Volume Deficit
Location: Brookfield WI, Baltimore MD, Arlington VA,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT06734351
Phase3, Recruiting
FeaturedActive & Responsive
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
for
Primary Open Angle Glaucoma
Location: Kenosha WI, Peoria IL, Fraser MI, Minneapolis MN,